62 related articles for article (PubMed ID: 15576986)
1. [The role of insulin receptor substrates in bone metabolism].
Akune T
Clin Calcium; 2004 Feb; 14(2):289-92. PubMed ID: 15576986
[TBL] [Abstract][Full Text] [Related]
2. [Involvement of insulin and IGF-1 signaling molecules in bone metabolism].
Ogata N; Kawaguchi H
Clin Calcium; 2008 May; 18(5):614-22. PubMed ID: 18445879
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.
Ogata N; Chikazu D; Kubota N; Terauchi Y; Tobe K; Azuma Y; Ohta T; Kadowaki T; Nakamura K; Kawaguchi H
J Clin Invest; 2000 Apr; 105(7):935-43. PubMed ID: 10749573
[TBL] [Abstract][Full Text] [Related]
4. [Hormones and osteoporosis update. Insulin/IGF-I and bone].
Kawaguchi H
Clin Calcium; 2009 Jul; 19(7):1015-25. PubMed ID: 19568000
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts.
Akune T; Ogata N; Hoshi K; Kubota N; Terauchi Y; Tobe K; Takagi H; Azuma Y; Kadowaki T; Nakamura K; Kawaguchi H
J Cell Biol; 2002 Oct; 159(1):147-56. PubMed ID: 12379806
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H
Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of insulin receptor substrate-1 impairs skeletal growth through early closure of epiphyseal cartilage.
Hoshi K; Ogata N; Shimoaka T; Terauchi Y; Kadowaki T; Kenmotsu S; Chung UI; Ozawa H; Nakamura K; Kawaguchi H
J Bone Miner Res; 2004 Feb; 19(2):214-23. PubMed ID: 14969391
[TBL] [Abstract][Full Text] [Related]
8. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
[TBL] [Abstract][Full Text] [Related]
9. Decreased lactation capacity and altered milk composition in insulin receptor substrate null mice is associated with decreased maternal body mass and reduced insulin-dependent phosphorylation of mammary Akt.
Hadsell DL; Olea W; Lawrence N; George J; Torres D; Kadowaki T; Lee AV
J Endocrinol; 2007 Aug; 194(2):327-36. PubMed ID: 17641282
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor substrate 1 (IRS-1) plays a unique role in normal epidermal physiology.
Sadagurski M; Nofech-Mozes S; Weingarten G; White MF; Kadowaki T; Wertheimer E
J Cell Physiol; 2007 Nov; 213(2):519-27. PubMed ID: 17508357
[TBL] [Abstract][Full Text] [Related]
11. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.
Freude S; Leeser U; Müller M; Hettich MM; Udelhoven M; Schilbach K; Tobe K; Kadowaki T; Köhler C; Schröder H; Krone W; Brüning JC; Schubert M
J Neurochem; 2008 Nov; 107(4):907-17. PubMed ID: 18717815
[TBL] [Abstract][Full Text] [Related]
12. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
13. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
15. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings.
Bartke A
Aging Cell; 2008 Jun; 7(3):285-90. PubMed ID: 18346217
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.
Sadagurski M; Yakar S; Weingarten G; Holzenberger M; Rhodes CJ; Breitkreutz D; Leroith D; Wertheimer E
Mol Cell Biol; 2006 Apr; 26(7):2675-87. PubMed ID: 16537911
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like effects of visfatin on human osteoblasts.
Xie H; Tang SY; Luo XH; Huang J; Cui RR; Yuan LQ; Zhou HD; Wu XP; Liao EY
Calcif Tissue Int; 2007 Mar; 80(3):201-10. PubMed ID: 17340225
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
19. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
20. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?
Di Paolo S; Teutonico A; Leogrande D; Capobianco C; Schena PF
J Am Soc Nephrol; 2006 Aug; 17(8):2236-44. PubMed ID: 16807405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
